Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-02 Sale | 2024-12-03 4:30 pm | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 555 | $5.64 | $3,130 | 7,255 (Direct) | View |
| 2024-05-14 Purchase | 2024-05-15 5:30 pm | Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks | 76,000 | $6.26 | $475,760 | 342,509 (Direct) | View |
| 2024-04-02 Sale | 2024-04-03 5:00 pm | Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer | 1,514 | $8.24 | $12,475 | 18,604 (Direct) | View |
| 2023-12-01 Purchase | 2023-12-05 4:30 pm | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 1,800,000 | $10 | $18,000,000 | 12,168,489 (Indirect) | View |
| 2023-11-29 Sale | 2023-12-01 4:30 pm | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 554 | $11.45 | $6,343 | 7,810 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-04 Gift | 2024-12-04 4:30 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 30,000 | $0 | 675,502 (Direct) | View |
| 2024-11-29 Exercise | 2024-12-03 4:30 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 1,875 | $0 | 7,255 (Direct) | View |
| 2024-06-28 Exercise | 2024-07-02 07:30 am | N/A N/A | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 30,000 | $2.87 | 1,248,430 (Direct) | View |
| 2024-06-28 Exercise | 2024-07-02 07:30 am | N/A 2030-09-15 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 30,000 | $0 | 1,248,430 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 07:45 am | N/A 2034-06-25 | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 136,139 | $0 | 136,139 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 07:45 am | N/A 2034-06-25 | Verve Therapeutics Inc. | VERV | Mikhail Sheila Director | 136,139 | $0 | 136,139 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 07:45 am | N/A 2034-06-25 | Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director | 136,139 | $0 | 136,139 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 07:45 am | N/A 2034-06-25 | Verve Therapeutics Inc. | VERV | Cumbo Alexander Director | 136,139 | $0 | 136,139 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 07:45 am | N/A 2034-06-25 | Verve Therapeutics Inc. | VERV | Tatsis Ourania Director | 267,541 | $0 | 267,541 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 07:45 am | N/A 2034-06-25 | Verve Therapeutics Inc. | VERV | Morrison Jodie Pope Director | 267,541 | $0 | 267,541 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 07:45 am | N/A 2034-06-25 | Verve Therapeutics Inc. | VERV | COATS LONNEL Director | 136,139 | $0 | 136,139 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-28 07:45 am | N/A 2034-06-25 | Verve Therapeutics Inc. | VERV | MacLean Michael F Director | 136,139 | $0 | 136,139 (Direct) | View |
Ownership | 2024-06-28 07:30 am | N/A N/A | Verve Therapeutics Inc. | VERV | Politi Jason Chief Technical Ops. Off. | 0 | $0 | 394,177 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-25 5:05 pm | N/A 2034-06-20 | Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer | 32,000 | $0 | 32,000 (Direct) | View |
Ownership | 2024-06-25 5:00 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer | 0 | $0 | 260,516 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 5:00 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer | 3,315 | $0 | 18,604 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:30 pm | N/A 2034-02-13 | Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks | 186,000 | $0 | 186,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:30 pm | N/A 2034-02-13 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 658,000 | $0 | 658,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:30 pm | N/A 2034-02-13 | Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer | 149,000 | $0 | 149,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:30 pm | N/A 2034-02-13 | Verve Therapeutics Inc. | VERV | Fiedorek Fred T. Chief Medical Officer | 112,000 | $0 | 112,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:30 pm | N/A 2034-02-13 | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:30 pm | N/A 2034-02-13 | Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2022-11-07 Ownership | 2024-02-09 5:00 pm | N/A N/A | Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director | 409,626 | $0 | 428,326 (Indirect) | View |
Ownership | 2023-12-05 4:50 pm | N/A N/A | Verve Therapeutics Inc. | VERV | GV 2023 GP L.L.C. GV 2023 GP L.P. GV 2023 L.P. Alphabet Inc. Member of 10% Group | 0 | $0 | 1,800,000 (Indirect) | View |
| 2023-11-29 Exercise | 2023-12-01 4:30 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 1,875 | $0 | 7,810 (Direct) | View |
| 2023-09-18 Option Award | 2023-09-19 5:05 pm | N/A 2033-09-17 | Verve Therapeutics Inc. | VERV | Fiedorek Fred T. Chief Medical Officer | 180,000 | $0 | 180,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:00 pm | N/A 2033-06-14 | Verve Therapeutics Inc. | VERV | MacLean Michael F Director | 26,642 | $0 | 26,642 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:00 pm | N/A 2033-06-14 | Verve Therapeutics Inc. | VERV | Cumbo Alexander Director | 26,642 | $0 | 26,642 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:00 pm | N/A 2033-06-14 | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 26,642 | $0 | 26,642 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:00 pm | N/A 2033-06-14 | Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director | 26,642 | $0 | 26,642 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:00 pm | N/A 2033-06-14 | Verve Therapeutics Inc. | VERV | COATS LONNEL Director | 26,642 | $0 | 26,642 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:00 pm | N/A 2033-06-14 | Verve Therapeutics Inc. | VERV | Mikhail Sheila Director | 26,642 | $0 | 26,642 (Direct) | View |
Ownership | 2023-02-23 5:00 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer | 0 | $0 | 242,940 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 5:00 pm | N/A 2033-02-13 | Verve Therapeutics Inc. | VERV | Bellinger Andrew CSO & CMO | 182,800 | $0 | 182,800 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 5:00 pm | N/A 2033-02-13 | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 182,800 | $0 | 182,800 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 5:00 pm | N/A 2033-02-13 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 550,200 | $0 | 550,200 (Direct) | View |